AnYuan Pharmaceutical

AnYuan Pharmaceutical is a clinical-stage biotechnology company based in Shanghai, China, specializing in the development of innovative biologics for metabolic, autoimmune, and ophthalmological diseases. The company leverages a proprietary protein engineering platform to design next-generation therapies, including multi-target agonists and long-acting fusion proteins. Its lead programs focus on high-prevalence conditions such as Type 2 diabetes, obesity, and chronic inflammatory disorders. AnYuan aims to address unmet medical needs by improving the efficacy and dosing convenience of existing therapeutic classes through advanced molecular design.